Form 4: Thermo Fisher CFO Sells Shares for Tax Obligations

Stephen Williamson, retiring Sr. VP and CFO of Thermo Fisher Scientific, disposed of common stock shares to cover tax liabilities.

Summary

• Stephen Williamson, the retiring Senior Vice President and Chief Financial Officer of Thermo Fisher Scientific Inc. (TMO), reported transactions involving the company's common stock.
• On February 28, 2026, Williamson disposed of a total of 921.793 shares (674.724 + 247.069) of common stock.
• These dispositions were made at a price of $521.11 per share and are indicated by transaction code "F," signifying a payment of tax liability by withholding securities.
• Following these transactions, Williamson directly beneficially owns 32,746.469 and 32,499.4 shares of common stock.
• Additionally, 12,674 shares are indirectly beneficially owned via a SLAT (Spousal Lifetime Access Trust), for which the reporting person disclaims beneficial ownership except to the extent of any pecuniary interest.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a routine executive stock transaction for tax purposes rather than a discretionary sale or purchase based on new information.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, as it is a report of an insider's stock transaction.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as those for tax withholding, are common and generally do not signal significant changes in company fundamentals or broader industry trends. This transaction is specific to an individual executive's equity management and is typical for executives in large-cap companies.

Comparison to Industry Standards

• This Form 4 filing details a standard executive stock transaction for tax purposes, which is a common occurrence across publicly traded companies, particularly for executives with significant equity compensation.
• The transaction price of $521.11 per share reflects the market value at the time of the transaction, consistent with how similar transactions are executed by executives in comparable life sciences or healthcare companies.

Management Changes

Related Party Transactions

• 12,674 shares are indirectly beneficially owned via a SLAT (Spousal Lifetime Access Trust), for which the reporting person disclaims beneficial ownership except to the extent of any pecuniary interest.

Stakeholder Impact

• Minimal direct impact on shareholders, employees, customers, suppliers, or creditors, as this is a routine personal financial transaction by an executive.

Key Dates

Recommendation

This Form 4 reports a routine disposition of shares by a retiring executive to cover tax obligations, which is a common practice and not indicative of a change in the company's underlying value or future prospects. It does not provide new information to warrant a change in investment recommendation.

Keywords

Thermo Fisher Scientific, TMO, Stephen Williamson, Form 4, Insider Transaction, Stock Sale, CFO, Tax Withholding, Equity Compensation